Found: 23
Select item for more details and to access through your institution.
Technological Barriers to Routine Genomic Surveillance for Vaccine Development Against SARS‐CoV‐2 in Africa: A Systematic Review.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70047
- By:
- Publication type:
- Article
Evaluating the Economic and Epidemiological Impact of RSV Hospitalizations in Southern Austria [Southern Austria Respiratory Syncytial Virus INpatient Investigation (ARNI Study)].
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70046
- By:
- Publication type:
- Article
Inpatient Burden of Respiratory Syncytial Virus Infection and Influenza in Children Younger Than 5 Years in Japan, 2011–2022: A Database Study.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70045
- By:
- Publication type:
- Article
Correction to 'Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain'.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70043
- Publication type:
- Article
Virological and Clinical Outcomes of Influenza Outpatients Treated With Baloxavir, Oseltamivir, or Laninamivir in the 2023–2024 Season.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70042
- By:
- Publication type:
- Article
An Outbreak of Respiratory Viral Infections in a Professional Ice Hockey Team.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70041
- By:
- Publication type:
- Article
Influenza in Adults Seeking Care at Seven European Emergency Departments: A Prospective Active Surveillance During the 2019–2020 Influenza Season.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70040
- By:
- Publication type:
- Article
Real‐World Assessment of Economic and Clinical Outcomes in Thai Patients With Respiratory Syncytial Virus Infection Across Age Groups: A Retrospective Cohort Analysis.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70039
- By:
- Publication type:
- Article
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS‐CoV‐2 Infection—Increasing Community Access to Testing Program, United States, January–September 2023.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70038
- By:
- Publication type:
- Article
Respiratory Diagnoses Year‐Round: Unraveling the Multifaceted Pediatric Infection Cycles.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70037
- By:
- Publication type:
- Article
Severe Neurological Complications With Influenza in Vietnamese Children.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70035
- By:
- Publication type:
- Article
Measures of Population Immunity Can Predict the Dominant Clade of Influenza A (H3N2) in the 2017–2018 Season and Reveal Age‐Associated Differences in Susceptibility and Antibody‐Binding Specificity.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70033
- By:
- Publication type:
- Article
The Burden of Seasonal Influenza and Its Potential Complications Among Older Japanese Adults: A Real‐World Database Study.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70032
- By:
- Publication type:
- Article
Factors Associated With Transmission Across Three Waves of SARS‐CoV‐2 in a Prospective Community‐Based Study of Households With School‐Aged Children—Dane County, Wisconsin, 2020–2022.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70031
- By:
- Publication type:
- Article
Expansion of Laboratory Capacity in the Eastern Mediterranean Region During the COVID‐19 Pandemic: Lessons Learned and Future Strategies for Sustainability.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70030
- By:
- Publication type:
- Article
Severe Acute Respiratory Infection (SARI) due to Influenza in Post‐COVID Resurgence: Disproportionate Impact on Older Māori and Pacific Peoples.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70029
- By:
- Publication type:
- Article
Effectiveness of Original Monovalent and Bivalent COVID‐19 Vaccines Against COVID‐19‐Associated Hospitalization and Severe In‐Hospital Outcomes Among Adults in the United States, September 2022–August 2023.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70027
- By:
- Publication type:
- Article
Trends in COVID‐19–Attributable Hospitalizations Among Adults With Laboratory‐Confirmed SARS‐CoV‐2—COVID‐NET, June 2020 to September 2023.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70021
- By:
- Publication type:
- Article
Improvement of RBD‐FC Immunogenicity by Using Alum–Sodium Alginate Adjuvant Against SARS‐COV‐2.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70018
- By:
- Publication type:
- Article
Impact of Age and Comorbid Conditions on Incidence Rates of COVID‐19‐Associated Hospitalizations, 2020–2021.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70016
- By:
- Publication type:
- Article
Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UK.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70014
- By:
- Publication type:
- Article
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.70009
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 11, p. 1, doi. 10.1111/irv.13163
- Publication type:
- Article